The US FDA has approved Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.
I was 50 years old at the time, and hearing this changed everything.     I’d been having annual mammograms since I was 41 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback